Table of Content


1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16

2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 34
2.4 Emerging Opportunities and Market Trends 37
2.5 Porter’s Fiver Forces Analysis 41

3 Segmentation of North America Market by Offering 45
3.1 Market Overview by Offering 45
3.2 Products 47
3.3.1 Probiotics 48
3.3.2 Prebiotics 49
3.3.3 Vitamins & Supplements 50
3.3 Testing Services 51
3.3.1 Nutrigenomics Clinical Testing 52
3.3.2 Nutrigenomics Research Testing 53

4 Segmentation of North America Market by Test Technology 54
4.1 Market Overview by Test Technology 54
4.2 Next-generation Sequencing 56
4.3 Real-time PCR 57
4.4 DNA Microarray 58
4.5 Sanger Sequencing 59

5 Segmentation of North America Market by Test Sample 60
5.1 Market Overview by Test Sample 60
5.2 Buccal Swab Sample 62
5.3 Saliva Sample 63
5.4 Blood Sample 64
5.5 Other Samples 65

6 Segmentation of North America Market by Application 66
6.1 Market Overview by Application 66
6.2 Women’s Health 68
6.3 Metabolic Disorders 69
6.4 Immune Health 70
6.5 Cancer Research 71
6.6 Cardiovascular Diseases 72
6.7 Diabetes 73
6.8 Other Applications 74

7 Segmentation of North America Market by End User 75
7.1 Market Overview by End User 75
7.2 Hospitals 77
7.3 Nutrition Clinics 78
7.4 Diagnostics Laboratories 79
7.5 Other End Users 80

8 North America Market 2021-2031 by Country 81
8.1 Overview of North America Market 81
8.2 U.S. 84
8.3 Canada 87
8.4 Mexico 89

9 Competitive Landscape 91
9.1 Overview of Key Vendors 91
9.2 New Product Launch, Partnership, Investment, and M&A 94
9.3 Company Profiles 95
BASF SE 95
BioGaia 97
Cell Logic 98
Cura Integrative Medicine 99
DNAfit 100
DuPont de Nemours, Inc. 101
Garden of Life, LLC 102
GeneOmbio 103
Genova Diagnostics, Inc. 104
GX Sciences, Inc. 105
Ingredion Incorporated 106
Jarrow Formulas Inc. 107
Koninklijke DSM N.V. 108
MedGenome 109
Metagenics, Inc. 110
Nutrigenomix Inc. 111
Unilever Group 112
XCODE Life 113
Yakult Honsha Co., Ltd. 114
RELATED REPORTS 115
?



List of Figures


List of Figures:

Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. North America Nutrigenomics Market, 2021-2031, $ mn 19
Figure 5. Impact of COVID-19 on Business 24
Figure 6. Primary Drivers and Impact Factors of North America Nutrigenomics Market 26
Figure 7. Number of Overweight/Obese People and Diabetic Population in the World, 1980, 2020, and 2045F, in million 29
Figure 8. Leading Causes of Death in the World, 2019-2020, million 31
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 32
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 32
Figure 11. Primary Restraints and Impact Factors of North America Nutrigenomics Market 34
Figure 12. Investment Opportunity Analysis 38
Figure 13. Porter’s Fiver Forces Analysis of North America Nutrigenomics Market 41
Figure 14. Breakdown of North America Nutrigenomics Market by Offering, 2021-2031, % of Revenue 46
Figure 15. North America Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%) 46
Figure 16. North America Nutrigenomics Market by Offering: Products, 2021-2031, $ mn 47
Figure 17. North America Nutrigenomics Market by Products: Probiotics, 2021-2031, $ mn 48
Figure 18. North America Nutrigenomics Market by Products: Prebiotics, 2021-2031, $ mn 49
Figure 19. North America Nutrigenomics Market by Products: Vitamins & Supplements, 2021-2031, $ mn 50
Figure 20. North America Nutrigenomics Market by Offering: Testing Services, 2021-2031, $ mn 51
Figure 21. North America Nutrigenomics Market by Testing Services: Nutrigenomics Clinical Testing, 2021-2031, $ mn 52
Figure 22. North America Nutrigenomics Market by Testing Services: Nutrigenomics Research Testing, 2021-2031, $ mn 53
Figure 23. Breakdown of North America Nutrigenomics Market by Test Technology, 2021-2031, % of Sales Revenue 55
Figure 24. North America Addressable Market Cap in 2022-2031 by Test Technology, Value ($ mn) and Share (%) 55
Figure 25. North America Nutrigenomics Market by Test Technology: Next-generation Sequencing, 2021-2031, $ mn 56
Figure 26. North America Nutrigenomics Market by Test Technology: Real-time PCR, 2021-2031, $ mn 57
Figure 27. North America Nutrigenomics Market by Test Technology: DNA Microarray, 2021-2031, $ mn 58
Figure 28. North America Nutrigenomics Market by Test Technology: Sanger Sequencing, 2021-2031, $ mn 59
Figure 29. Breakdown of North America Nutrigenomics Market by Test Sample, 2021-2031, % of Sales Revenue 61
Figure 30. North America Addressable Market Cap in 2022-2031 by Test Sample, Value ($ mn) and Share (%) 61
Figure 31. North America Nutrigenomics Market by Test Sample: Buccal Swab Sample, 2021-2031, $ mn 62
Figure 32. North America Nutrigenomics Market by Test Sample: Saliva Sample, 2021-2031, $ mn 63
Figure 33. North America Nutrigenomics Market by Test Sample: Blood Sample, 2021-2031, $ mn 64
Figure 34. North America Nutrigenomics Market by Test Sample: Other Samples, 2021-2031, $ mn 65
Figure 35. Breakdown of North America Nutrigenomics Market by Application, 2021-2031, % of Revenue 67
Figure 36. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 67
Figure 37. North America Nutrigenomics Market by Application: Women’s Health, 2021-2031, $ mn 68
Figure 38. North America Nutrigenomics Market by Application: Metabolic Disorders, 2021-2031, $ mn 69
Figure 39. North America Nutrigenomics Market by Application: Immune Health, 2021-2031, $ mn 70
Figure 40. North America Nutrigenomics Market by Application: Cancer Research, 2021-2031, $ mn 71
Figure 41. North America Nutrigenomics Market by Application: Cardiovascular Diseases, 2021-2031, $ mn 72
Figure 42. North America Nutrigenomics Market by Application: Diabetes, 2021-2031, $ mn 73
Figure 43. North America Nutrigenomics Market by Application: Other Applications, 2021-2031, $ mn 74
Figure 44. Breakdown of North America Nutrigenomics Market by End User, 2021-2031, % of Revenue 76
Figure 45. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 76
Figure 46. North America Nutrigenomics Market by End User: Hospitals, 2021-2031, $ mn 77
Figure 47. North America Nutrigenomics Market by End User: Nutrition Clinics, 2021-2031, $ mn 78
Figure 48. North America Nutrigenomics Market by End User: Diagnostics Laboratories, 2021-2031, $ mn 79
Figure 49. North America Nutrigenomics Market by End User: Other End Users, 2021-2031, $ mn 80
Figure 50. Breakdown of North America Nutrigenomics Market by Country, 2021 and 2031, % of Revenue 82
Figure 51. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 83
Figure 52. U.S. Nutrigenomics Market, 2021-2031, $ mn 85
Figure 53. Canada Nutrigenomics Market, 2021-2031, $ mn 87
Figure 54. Nutrigenomics Market in Mexico, 2021-2031, $ mn 89
Figure 55. Growth Stage of North America Nutrigenomics Industry over the Forecast Period 91

List of Tables


List of Tables:

Table 1. Snapshot of North America Nutrigenomics Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Economic Outlook, 2021-2023 22
Table 4. World Health Spending by Region, $ bn, 2013-2020 33
Table 5. Main Product Trends and Market Opportunities in North America Nutrigenomics Market 37
Table 6. North America Nutrigenomics Market by Offering, 2021-2031, $ mn 45
Table 7. North America Nutrigenomics Market: Products by Type, 2021-2031, $ mn 47
Table 8. North America Nutrigenomics Market: Testing Services by Type, 2021-2031, $ mn 51
Table 9. North America Nutrigenomics Market by Test Technology, 2021-2031, $ mn 54
Table 10. North America Nutrigenomics Market by Test Sample, 2021-2031, $ mn 60
Table 11. North America Nutrigenomics Market by Application, 2021-2031, $ mn 66
Table 12. North America Nutrigenomics Market by End User, 2021-2031, $ mn 75
Table 13. North America Nutrigenomics Market by Country, 2021-2031, $ mn 82
Table 14. U.S. Nutrigenomics Market by Offering, 2021-2031, $ mn 86
Table 15. U.S. Nutrigenomics Market by Application, 2021-2031, $ mn 86
Table 16. U.S. Nutrigenomics Market by End User, 2021-2031, $ mn 86
Table 17. Canada Nutrigenomics Market by Offering, 2021-2031, $ mn 88
Table 18. Canada Nutrigenomics Market by Application, 2021-2031, $ mn 88
Table 19. Canada Nutrigenomics Market by End User, 2021-2031, $ mn 88
Table 20. Mexico Nutrigenomics Market by Offering, 2021-2031, $ mn 90
Table 21. Mexico Nutrigenomics Market by Application, 2021-2031, $ mn 90
Table 22. Mexico Nutrigenomics Market by End User, 2021-2031, $ mn 90
Table 23. BASF SE: Company Snapshot 95
Table 24. BASF SE: Business Segmentation 96
Table 25. BASF SE: Product Portfolio 96